Invesco
BHVN

Invesco’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Invesco’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,416
Closed -$4.45M – 4128
2022
Q3 		$4.45M Sell
29,416
-46,097
-61% -$6.83M ﹤0.01% 2296
2022
Q2 		$11M Sell
75,513
-72,419
-49% -$9.25M ﹤0.01% 1779
2022
Q1 		$17.5M Sell
147,932
-77,433
-34% -$9.66M ﹤0.01% 1588
2021
Q4 		$31.1M Buy
225,365
+79,404
+54% +$10.1M 0.01% 1274
2021
Q3 		$20.3M Buy
145,961
+66,154
+83% +$8.26M 0.01% 1557
2021
Q2 		$7.75M Buy
79,807
+66,845
+516% +$5.43M ﹤0.01% 2213
2021
Q1 		$886K Buy
12,962
+2,604
+25% +$211K ﹤0.01% 3098
2020
Q4 		$888K Buy
10,358
+7,030
+211% +$596K ﹤0.01% 2982
2020
Q3 		$217K Sell
3,328
-12,302
-79% -$806K ﹤0.01% 3437
2020
Q2 		$1.14M Buy
+15,630
New +$832K ﹤0.01% 2745
2020
Q1 		– Sell
-252,670
Closed -$13.8M – 3833
2019
Q4 		$13.8M Sell
252,670
-8,469
-3% -$419K ﹤0.01% 1593
2019
Q3 		$10.9M Buy
261,139
+51,706
+25% +$2.18M ﹤0.01% 1696
2019
Q2 		$9.17M Buy
209,433
+20,312
+11% +$1.14M ﹤0.01% 1803
2019
Q1 		$9.73M Sell
189,121
-19,920
-10% -$861K ﹤0.01% 1587
2018
Q4 		$7.73M Buy
+209,041
New +$7.54M ﹤0.01% 1674
2018
Q1 		– Sell
-27,723
Closed -$748K – 3852
2017
Q4 		$748K Buy
+27,723
New +$763K ﹤0.01% 3141

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Invesco's BHVN Position: Q4 2022 in Review

Invesco sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 29,416 shares — an estimated $4.45M sold.

Invesco first reported a position in BHVN in Q4 2017 and held it in 16 quarters. The position peaked at $31.1M in Q4 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Invesco reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Invesco sold 29,416 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $4.45M.
  • Invesco first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 16 quarters.
  • Invesco's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $31.1M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.